The Relative Strength (RS) Rating for ICU Medical entered a new percentile Thursday, with an increase from 72 to 88.
This exclusive rating from Investor's Business Daily measures price performance with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the last 52 weeks holds up against all the other stocks in our database.
Decades of market research reveals that the market's biggest winners tend to have an RS Rating of at least 80 in the early stages of their moves.
Hone Your Stock-Picking Skills By Focusing On These Factors
While it's not currently an ideal time to buy shares, see if the stock manages to form a base and break out.
Earnings grew 34% last quarter, up from 1% in the prior report. Revenue also increased, from 6% to 7%.
The company earns the No. 18 rank among its peers in the Medical-Products industry group. Boston Scientific, Pro-Dex and Axogen are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
